THE EFFECT OF TEZEPELUMAB ON EXACERBATIONS IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA ACCORDING TO BASELINE INHALED CORTICOSTEROID DOSE: RESULTS FROM THE PHASE 2B PATHWAY STUDY

被引：0
|
作者：
Corren, Jonathan
Ambrose, Christopher
Salapa, Kinga
Parnes, Jane
Colice, Gene
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.070
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：30A / 31A
页数：2
相关论文
共 50 条
  • [21] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study
    Kraft, M.
    Chupp, G. L.
    Reeh, K.
    Lindsley, A. W.
    Cook, B.
    Hunter, G.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [22] Tezepelumab Reduces Exacerbations Across All Seasons In Patients With Severe, Uncontrolled Asthma With Seasonal Allergy: Results From The Phase 3 NAVIGATOR Study
    Corren, Jonathan
    Lindsley, Andrew
    Spahn, Joseph
    Cook, Bill
    Griffiths, Janet
    Martin, Nicole
    Colice, Gene
    Pavord, Ian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB194 - AB194
  • [23] Effect of Tezepelumab in Oral Corticosteroid-Dependent Patients with Severe Asthma: Results From the Phase 3 NAVIGATOR Study
    Menzies-Gow, A.
    Brightling, C. E.
    Ambrose, C. S.
    Cook, B.
    Hellgvist, A.
    Ackert, J. Llanos
    Colice, G.
    Wechsler, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [24] Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
    Emson, C.
    Corren, J.
    Salapa, K.
    Hellqvist, A.
    Parnes, J. R.
    Colice, G.
    ALLERGY, 2020, 75 : 19 - 20
  • [25] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study
    Carr, Tara
    Bernstein, Jonathan
    Cook, Bill
    Hunter, Gillian
    Ambrose, Chris
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB152 - AB152
  • [26] The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
    Corren, J.
    Colice, G.
    Salapa, K.
    Bowen, K.
    Llanos-Ackert, J.
    ALLERGY, 2020, 75 : 19 - 19
  • [27] Effect of Tezepelumab on Exercise Tolerance in Patients With Severe, Uncontrolled Asthma From the NAVIGATOR Study
    Lugogo, N. L.
    Kraft, M.
    Corren, J.
    Martin, N.
    Shenoy, K. V.
    Shenoy, S. F.
    Chandarana, S.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [28] Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Ambrose, Christopher S.
    Colice, Gene
    Hunter, Gillian
    Cook, Bill
    Molfino, Nestor A.
    Llanos, Jean-Pierre
    Israel, Elliot
    ADVANCES IN THERAPY, 2023, 40 (11) : 4957 - 4971
  • [29] EFFECT OF TEZEPELUMAB ON LUNG FUNCTION IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN THE PHASE 3 NAVIGATOR STUDY
    Israel, Elliot
    Menzies-Gow, Andrew
    Colice, Gene
    Ambrose, Christopher
    Hunter, Gillian
    Cook, William
    Molfino, Nestor
    Llanos-Ackert, Jean-Pierre
    CHEST, 2021, 160 (04) : 41A - 43A
  • [30] Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Andrew Menzies-Gow
    Christopher S. Ambrose
    Gene Colice
    Gillian Hunter
    Bill Cook
    Nestor A. Molfino
    Jean-Pierre Llanos
    Elliot Israel
    Advances in Therapy, 2023, 40 : 4957 - 4971
12345